Since aberrant activation of STAT3 plays a critical role in the development of human cancers, including MM [27], numerous studies have tried to identify novel anticancer strategies/agents targeting STAT3 [27,31]. This evidence concerns the gene STAT3 and Miyoshi myopathy.